In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...

A light-sensitive polymer changes how it conducts heat and lithium ions by switching molecular order, revealing a path toward ...

CRGO action is characterized by high volatility and markedly irregular yield distribution: the 5-year beta is about 1.11, ...

A notorious weak spot in Earth’s magnetic shield is growing larger and weaker. This is the conclusion of a new analysis of ...